Inhalation Saturday, February 04, 2012
Current Issue

Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.

Cover photo courtesy of
Molkerei Meggle Wasserburg GmbH & Co.




 
This Month's Focus: Contract Testing and Product Development
Critical evaluation of the revised and new USP chapters for aerosols: <601> and <5> [Pharm Forum 2011; 37(4)] (Free)
This is the first of two articles, to be published by Inhalation, presenting opinions from representatives of IPAC-RS on the proposed new and revised USP Chapters for Aerosols <601> and <5>.
 
Redundancy Based Development (RBD) for a dry powder inhaler
Inspired by Toyota’s methods, a new approach to inhalation product development helps avoid costly, time-consuming delays
 
General Features
 
Elastomers in orally inhaled and nasal drug products Part I: Elastomer selection and qualification
A rationalized, risk-based approach to elastomer selection and qualification is critical for OINDP quality and safety. This is the first of a two-part series of articles on elastomers to be published by Inhalation.
 
2012 Editorial Calendar
February
April
June
August
October
December

Coming Next Issue
Inhalable dry powder formulations for low water soluble products
Particle sizing techniques for characterizing nasal drug delivery systems
Restriction of the delivered dose uniformity criteria in revised USP Chapter <601>
      Copyright 2012, CSC Publishing Inc. ALL Rights Reserved * Privacy policy